StockWatch
·

Jubilant Pharmova Ltd Q4 FY25 Results

JUBLPHARMAQ4 FY25 Results
Filing
MetricValue (₹ Cr)vs Q3 FY25
Revenue1.9K5.9%
Total Income1.9K6.0%
Expenditure1.7K3.0%
PBT206.1057.6%
Net Profit151.3050.3%
OPM17.74%19.13pp
NPM7.80%2.28pp
EPS9.7152.4%
View full financials

Informational and educational content only. Not investment advice.